₹ 850.55
Key Takeaways
Risk factor
Very poor trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Astec LifeSciences Limited, together with its subsidiaries, manufactures, distributes, and sells agrochemicals active ingredients and pharmaceutical intermediates in India. It manufactures a range of fungicides, insecticides, herbicides, and intermediates, such as triazole fungicides, heterocyclic herbicides, sulfonyl urea herbicides, synthetic pyrethroids, alkyl and aryl magnesium halides, mixed metal halides, and silane derivatives; fluorinated aromatic amines, pyridine...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, 'ex
Target Price
The average target price of ASTEC.NS is 801 and suggests 6% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to d
